# Mylan Laboratories Limited (FDF-2), Aurangabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/mylan-laboratories-limited-fdf-2/1bcb64f5-f3f2-412e-81da-b3efab26f310

> Inspection records and compliance data for Mylan Laboratories Limited (FDF-2) in Aurangabad. 6 FDA inspections on record, 1 Form 483, last inspected February 03, 2023.

---

## Details

- Name: Mylan Laboratories Limited (FDF-2)
- FEI Number: 3008316970
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: H-12 & H-13 Midc, Waluj
- City: Aurangabad
- Country Name: India
- Address: H-12 & H-13 Midc, Waluj, Aurangabad, India
- Country: India

## Related Documents

- [483 - Mylan Laboratories Limited (FDF-2) - 2026-08-25](https://www.keypedia.com/records/483/mylan-laboratories-limited-fdf-2/09b1a8a3-d1e1-4e0e-a996-3f6b9669015e) — source: FDA, date: August 25, 2026
- [FDA Inspection 1253435 - Mylan Laboratories Limited (FDF-2) - 2023-02-03](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/c86b2c6d-3939-43ca-9c49-3ab1f5c1b33f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 3, 2023
- FDA Inspection 1122884 - Mylan Laboratories Limited (FDF-2) - 2020-02-28 — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2020
- FDA Inspection 1091217 - Mylan Laboratories Limited (FDF-2) - 2019-04-26 — classification: No Action Indicated (NAI), source: FDA, date: April 26, 2019
- [FDA Inspection 1012796 - Mylan Laboratories Limited (FDF-2) - 2017-05-26](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/c3b3d8ef-b5cf-4868-ab95-1933bf124403) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2017
- [FDA Inspection 884211 - Mylan Laboratories Limited (FDF-2) - 2014-05-16](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/53ebc2c6-eeb9-4b2d-8a99-ac4237992fe3) — classification: No Action Indicated (NAI), source: FDA, date: May 16, 2014
- FDA Inspection 775616 - Mylan Laboratories Limited (FDF-2) - 2012-03-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2012

## Related Companies

- [Senador Laboratories Private Limited](https://www.keypedia.com/companies/senador-laboratories-private-limited/07781b9f-6d88-4334-96e4-438175fbaf9d)
- [Mipharm S.p.A.](https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Daiichi Sankyo Europe GmbH](https://www.keypedia.com/companies/daiichi-sankyo-europe-gmbh/772636a4-cbb8-47ae-8aa1-fdc45ab325f6)
- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/92dc52fe-a8d7-4a23-bc34-be68892d8866)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/7c50db23-6cc7-4100-bc80-c02d3aa7f85a)
- [Cosette Pharmaceuticals NC Laboratories, LLC](https://www.keypedia.com/companies/cosette-pharmaceuticals-nc-laboratories-llc/4f90e360-99ea-4457-a022-4950a8ea7644)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [Nostrum Laboratories, Inc.](https://www.keypedia.com/companies/nostrum-laboratories-inc/c9042755-fe46-4113-b071-6c8168af53e2)
- [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5)

## Related Officers

- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)